Lieberman M, Hansteen G A, McCune J M, Scott M L, White J H, Weissman I L
Department of Radiology, Stanford University School of Medicine, California 94305.
J Exp Med. 1987 Dec 1;166(6):1883-93. doi: 10.1084/jem.166.6.1883.
The transmission of a lymphomagenic agent(s) from the bone marrow of irradiated mice to thymic target cells has been demonstrated by: (a) the induction of T cell lymphomas in nonirradiated thymic grafts implanted in irradiated, Thy-l-congenic mice, (b) the induction of T cell lymphomas of host origin in mice infused with bone marrow from irradiated, Thy-l-congenic donors. The latter procedure also yields an appreciable number of pre-B cell lymphomas of uncertain origin. The results confirm Kaplan's theory that radiation induces thymic lymphomas in mice by an indirect mechanism. However, the previously described radiation leukemia virus is clearly not involved in the majority of transferred lymphomas. We propose that the mediating agent in radiation lymphomagenesis is a novel, transmissible agent induced in the bone marrow, but exerting its transforming activity on cells in the thymus. The nature and mode of action of the agent are under investigation.
(a) 在植入受照射的Thy-1同基因小鼠体内的未受照射胸腺移植物中诱导T细胞淋巴瘤;(b) 在输注来自受照射的Thy-1同基因供体的骨髓的小鼠中诱导宿主来源的T细胞淋巴瘤。后一种方法还产生了数量可观的来源不明的前B细胞淋巴瘤。这些结果证实了卡普兰的理论,即辐射通过间接机制在小鼠中诱导胸腺淋巴瘤。然而,先前描述的辐射白血病病毒显然与大多数转移的淋巴瘤无关。我们提出,辐射致淋巴瘤作用中的介导因子是一种在骨髓中诱导产生的新型可传播因子,但对胸腺中的细胞发挥其转化活性。该因子的性质和作用方式正在研究中。